Quest DiagnosticsDGXEarnings & Financial Report
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
DGX Q3 2025 Key Financial Metrics
营收
$2.8B
毛利润
$949.0M
营业利润
$386.0M
净利润
$245.0M
毛利率
33.7%
营业利润率
13.7%
净利率
8.7%
同比增长
13.2%
EPS
$2.16
资金流向
Quest Diagnostics Q3 2025 Financial Summary
Quest Diagnostics reported revenue of $2.8B for Q3 2025, with a net profit of $245.0M (8.7% margin). Cost of goods sold was $1.9B, operating expenses totaled $563.0M.
Key Financial Metrics
| Total Revenue | $2.8B |
|---|---|
| Net Profit | $245.0M |
| Gross Margin | 33.7% |
| Operating Margin | 13.7% |
| Report Period | Q3 2025 |
Quest Diagnostics Annual Revenue by Year
Quest Diagnostics annual revenue history includes year-by-year totals (for example, 2024 revenue was $9.9B).
| Year | Annual Revenue |
|---|---|
| 2024 | $9.9B |
| 2023 | $9.3B |
| 2022 | $9.9B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $2.29B | $2.37B | $2.40B | $2.49B | $2.62B | $2.65B | $2.76B | $2.82B |
| 同比增长 | -1.9% | 1.5% | 2.5% | 8.4% | 14.6% | 12.1% | 15.2% | 13.2% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $14.02B | $13.95B | $13.88B | $16.09B | $16.15B | $15.80B | $15.97B | $16.20B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $6.31B | $6.43B | $6.62B | $6.81B | $6.78B | $6.93B | $7.23B | $7.26B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $527.0M | $154.0M | $360.0M | $356.0M | $464.0M | $314.0M | $544.0M | $563.0M |
Other Health Care Companies
CI
Cigna
营收
$69.7B
净利润
N/A
CVS
CVS Health
营收
$105.7B
净利润
$2.9B
DVA
DaVita
营收
$3.6B
净利润
$234.2M
LH
Labcorp
营收
$3.6B
净利润
$261.1M
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B